L. Kerp

1.7k total citations
81 papers, 799 citations indexed

About

L. Kerp is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Kerp has authored 81 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Kerp's work include Diabetes and associated disorders (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Diabetes Management and Research (11 papers). L. Kerp is often cited by papers focused on Diabetes and associated disorders (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Diabetes Management and Research (11 papers). L. Kerp collaborates with scholars based in Germany, Denmark and Japan. L. Kerp's co-authors include K.‐G. Petersen, Rainer H. Straub, J Roubíček, W Pöldinger, B. von Graffenried, Emilio del Pozo, Kathrin Schlüter, E. Nüesch, E. del Pozo and Peter Marbach and has published in prestigious journals such as Nature, Diabetes Care and Diabetes.

In The Last Decade

L. Kerp

74 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Kerp Germany 15 294 217 174 135 110 81 799
Jürg Girard Switzerland 13 458 1.6× 183 0.8× 86 0.5× 145 1.1× 82 0.7× 18 914
Curtis R. Partington United States 14 175 0.6× 262 1.2× 102 0.6× 56 0.4× 145 1.3× 27 999
Gordon F. Anderson United States 18 153 0.5× 202 0.9× 162 0.9× 29 0.2× 146 1.3× 45 1.0k
D. R. Weightman United Kingdom 18 420 1.4× 114 0.5× 81 0.5× 44 0.3× 102 0.9× 38 908
Susan Firestone United States 11 677 2.3× 230 1.1× 261 1.5× 125 0.9× 79 0.7× 26 1.3k
Giorgio Trasforini Italy 20 713 2.4× 233 1.1× 432 2.5× 123 0.9× 231 2.1× 58 1.3k
D. Ikkos Sweden 17 249 0.8× 236 1.1× 107 0.6× 181 1.3× 22 0.2× 49 889
Jacques Corvilain Belgium 17 381 1.3× 188 0.9× 96 0.6× 110 0.8× 39 0.4× 82 1.1k
F.L. Mastaglia Australia 18 77 0.3× 363 1.7× 145 0.8× 53 0.4× 174 1.6× 53 1.0k
Sheila Fraser United Kingdom 17 308 1.0× 101 0.5× 341 2.0× 68 0.5× 100 0.9× 40 1.0k

Countries citing papers authored by L. Kerp

Since Specialization
Citations

This map shows the geographic impact of L. Kerp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Kerp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Kerp more than expected).

Fields of papers citing papers by L. Kerp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Kerp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Kerp. The network helps show where L. Kerp may publish in the future.

Co-authorship network of co-authors of L. Kerp

This figure shows the co-authorship network connecting the top 25 collaborators of L. Kerp. A scholar is included among the top collaborators of L. Kerp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Kerp. L. Kerp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuler, Gerhard, et al.. (2008). »Lupus-Antikoagulans« bei Immunhyperthyreose. DMW - Deutsche Medizinische Wochenschrift. 115(40). 1511–1514. 1 indexed citations
2.
Rössle, Martin, et al.. (2008). Pulsatile Insulinsekretion in die Pfortader bei Leberzirrhose. DMW - Deutsche Medizinische Wochenschrift. 118(5). 134–138. 4 indexed citations
3.
Marbach, Peter, et al.. (1993). A time-resolved fluoroimmunoassay for human insulin based on two monoclonal antibodies. Journal of Immunological Methods. 157(1-2). 197–201. 7 indexed citations
4.
Wolff-Vorbeck, Guido, et al.. (1993). In vivo labelling of the spleen with a red-fluorescent cell dye. Journal of Immunological Methods. 165(1). 121–125. 11 indexed citations
5.
Straub, Rainer H., Andreas Jeron, & L. Kerp. (1992). The Pupillary Light Reflex. Ophthalmologica. 204(3). 143–148. 18 indexed citations
6.
Pelz, Klaus, et al.. (1992). Is the reuse of needles for insulin injection systems associated with a higher risk of cutaneous complications?. Diabetes Research and Clinical Practice. 16(3). 209–212. 27 indexed citations
7.
Kerp, L., et al.. (1992). Osmotic Stress Due to Changes in Plasma Glucose and its Regulation in IDDM Patients. Hormone and Metabolic Research. 24(8). 375–378. 1 indexed citations
8.
Böcker, J., et al.. (1991). Urine Screening in Outdoor Volunteers: Day Versus Night Versus 24 Hour Collection. Clinical Chemistry and Laboratory Medicine (CCLM). 29(3). 185–8. 9 indexed citations
9.
Kerp, L., et al.. (1989). IgE antibodies to insulin and related peptides, a result of insulin treatment?. Diabetes Research and Clinical Practice. 7(1). 41–46. 1 indexed citations
10.
Kerp, L., et al.. (1989). Natural occurrence of IgE antibodies to peptide hormones in man. European Journal of Clinical Investigation. 19(5). 464–465. 1 indexed citations
11.
Zeisel, Hans, et al.. (1989). IgE antibodies to human growth hormone prior to and during treatment. European Journal of Endocrinology. 121(4). 501–504. 4 indexed citations
12.
Petersen, K.‐G. & L. Kerp. (1988). β2-Sympathomimetic Activation as a Cause of Posthypoglycemic Glucose Intolerance. Hormone and Metabolic Research. 20(3). 171–174. 3 indexed citations
13.
Petersen, K.‐G., et al.. (1984). Evidence for coronary spasm during flushing in the carcinoid syndrome. Clinical Cardiology. 7(8). 445–448. 8 indexed citations
14.
Kerp, L., et al.. (1983). Beta-adrenoceptor blocking agents induce different counter-regulatory responses to insulin.. PubMed. 14 Suppl 2. 49–60. 6 indexed citations
15.
Kerp, L., et al.. (1976). High and low affinity insulin antibodies.. PubMed. 205. 211–22. 5 indexed citations
16.
Kerp, L.. (1975). [Membrane specificity for hormones].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 81. 786–99.
17.
Kerp, L.. (1971). Quantitative Data Concerning the Localisation of Antibody Binding Sites on Insulin and Proinsulin Molecules. International Archives of Allergy and Immunology. 41(1). 216–218. 1 indexed citations
18.
Kerp, L., et al.. (1970). Vergleichende analyse der gegen rinderproinsulin und rinderinsulin gebildeten antikörper. FEBS Letters. 8(3). 157–160. 1 indexed citations
19.
Schubothe, H., et al.. (1967). Hämolytisch-urämisches Syndrom im Erwachsenenalter. Annals of Hematology. 15(2). 65–70. 6 indexed citations
20.
Kerp, L., et al.. (1961). Komplexbildung biogener Amine mit Serumalbumin in Korrelation zur Hemmwirkung von Albumin im biologischen Test. Journal of Molecular Medicine. 39(17). 917–922. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026